• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Antifungal susceptibilities, varieties, and electrophoretic karyotypes of clinical isolates of Cryptococcus neoformans from Brazil, Chile, and Venezuela.来自巴西、智利和委内瑞拉的新型隐球菌临床分离株的抗真菌药敏性、种类及电泳核型
J Clin Microbiol. 2001 Jun;39(6):2348-50. doi: 10.1128/JCM.39.6.2348-2350.2001.
2
Molecular typing and antifungal susceptibility of clinical sequential isolates of Cryptococcus neoformans from Sao Paulo State, Brazil.巴西圣保罗州新型隐球菌临床连续分离株的分子分型及抗真菌药敏试验
FEMS Yeast Res. 2007 Jan;7(1):152-64. doi: 10.1111/j.1567-1364.2006.00128.x.
3
Molecular typing and antifungal susceptibility of clinical and environmental Cryptococcus neoformans species complex isolates in Goiania, Brazil.巴西戈亚尼亚临床和环境新型隐球菌种复合体分离株的分子分型和抗真菌药敏试验。
Mycoses. 2010 Jan;53(1):62-7. doi: 10.1111/j.1439-0507.2008.01662.x. Epub 2009 Jun 4.
4
Molecular subtypes and antifungal susceptibilities of serial Cryptococcus neoformans isolates in human immunodeficiency virus-associated Cryptococcosis. Cryptococcal Disease Active Surveillance Group.人类免疫缺陷病毒相关隐球菌病中新型隐球菌系列分离株的分子亚型及抗真菌药敏性。隐球菌病主动监测小组
J Infect Dis. 1996 Oct;174(4):812-20. doi: 10.1093/infdis/174.4.812.
5
In vitro susceptibilities of clinical and environmental isolates of Cryptococcus neoformans to five antifungal drugs.新型隐球菌临床分离株和环境分离株对五种抗真菌药物的体外敏感性
Antimicrob Agents Chemother. 1996 Mar;40(3):822-4. doi: 10.1128/AAC.40.3.822.
6
Susceptibility of clinical isolates of Cryptococcus neoformans to amphotericin B using time-kill methodology.采用时间杀菌法检测新型隐球菌临床分离株对两性霉素B的敏感性。
Diagn Microbiol Infect Dis. 2009 Jun;64(2):146-51. doi: 10.1016/j.diagmicrobio.2009.02.007. Epub 2009 Apr 2.
7
Electrophoretic karyotype and in vitro antifungal susceptibility of Cryptococcus neoformans isolates from AIDS patients.艾滋病患者新型隐球菌分离株的电泳核型及体外抗真菌药敏性
Diagn Microbiol Infect Dis. 1995 Nov;23(3):99-103. doi: 10.1016/0732-8893(95)00169-7.
8
Human cryptococcosis: relationship of environmental and clinical strains of Cryptococcus neoformans var. neoformans from urban and rural areas.人类隐球菌病：城乡地区新型隐球菌新型变种环境菌株与临床菌株的关系
Mycopathologia. 2005 Jan;159(1):7-11. doi: 10.1007/s11046-004-9618-4.
9
Genotyping and antifungal susceptibility testing of Cryptococcus neoformans isolates from Cameroonian HIV-positive adult patients.对来自喀麦隆 HIV 阳性成年患者的新型隐球菌分离株进行基因分型和抗真菌药敏试验。
Clin Microbiol Infect. 2013 Aug;19(8):763-9. doi: 10.1111/1469-0691.12019. Epub 2012 Oct 3.
10
Phenotypic switching and genetic diversity of Cryptococcus neoformans.新型隐球菌的表型转换与遗传多样性
J Clin Microbiol. 2001 Jun;39(6):2060-4. doi: 10.1128/JCM.39.6.2060-2064.2001.

引用本文的文献

1
and Species Complexes in Latin America: A Map of Molecular Types, Genotypic Diversity, and Antifungal Susceptibility as Reported by the Latin American Cryptococcal Study Group.拉丁美洲的隐球菌及物种复合体：拉丁美洲隐球菌研究小组报告的分子类型、基因型多样性和抗真菌药敏性图谱
J Fungi (Basel). 2021 Apr 9;7(4):282. doi: 10.3390/jof7040282.
2
The status of cryptococcosis in Latin America.拉丁美洲隐球菌病的现状。
Mem Inst Oswaldo Cruz. 2018;113(7):e170554. doi: 10.1590/0074-02760170554. Epub 2018 Apr 5.
3
ANTIFUNGAL SUSCEPTIBILITY TESTING AND GENOTYPING CHARACTERIZATION OF Cryptococcus neoformans AND gattii ISOLATES FROM HIV-INFECTED PATIENTS OF RIBEIRÃO PRETO, SÃO PAULO, BRAZIL.来自巴西圣保罗州里贝朗普雷图市艾滋病病毒感染患者的新型隐球菌和格特隐球菌分离株的抗真菌药敏试验及基因分型特征分析
Rev Inst Med Trop Sao Paulo. 2016 Sep 22;58:69. doi: 10.1590/S1678-9946201658069.
4
Cryptococcus gattii infections.加氏隐球菌感染
Clin Microbiol Rev. 2014 Oct;27(4):980-1024. doi: 10.1128/CMR.00126-13.
5
Cryptococcosis: epidemiology, fungal resistance, and new alternatives for treatment. cryptococcosis：流行病学、真菌耐药性和新的治疗选择。
Eur J Clin Microbiol Infect Dis. 2013 Nov;32(11):1377-91. doi: 10.1007/s10096-013-1915-8. Epub 2013 Jul 4.
6
Flucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungal.氟胞嘧啶与隐球菌病：是时候紧急解决全球范围内使用一种有 50 年历史的抗真菌药物的可及性问题了。
J Antimicrob Chemother. 2013 Nov;68(11):2435-44. doi: 10.1093/jac/dkt221. Epub 2013 Jun 20.
7
Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for amphotericin B and flucytosine.新型隐球菌-格特隐球菌种复合体：两性霉素 B 和氟胞嘧啶野生型药敏终点分布及流行病学折点的国际研究。
Antimicrob Agents Chemother. 2012 Jun;56(6):3107-13. doi: 10.1128/AAC.06252-11. Epub 2012 Mar 5.
8
Microbiological characteristics of clinical isolates of Cryptococcus spp. in Bahia, Brazil: molecular types and antifungal susceptibilities.巴西巴伊亚州隐球菌属临床分离株的微生物学特征：分子型和抗真菌药敏性。
Eur J Clin Microbiol Infect Dis. 2012 Jul;31(7):1647-52. doi: 10.1007/s10096-011-1488-3. Epub 2012 Jan 26.
9
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-year analysis of susceptibilities of noncandidal yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing.1997年至2007年ARTEMIS DISK全球抗真菌监测研究结果：采用CLSI标准化纸片扩散法对非念珠菌酵母菌种对氟康唑和伏立康唑敏感性进行的10.5年分析。
J Clin Microbiol. 2009 Jan;47(1):117-23. doi: 10.1128/JCM.01747-08. Epub 2008 Nov 12.
10
Cryptococcus neoformans, Cryptococcus gattii: serotypes in Venezuela.新型隐球菌、格特隐球菌：委内瑞拉的血清型
Mycopathologia. 2008 Sep;166(3):149-53. doi: 10.1007/s11046-008-9132-1. Epub 2008 May 30.

本文引用的文献

1
Prevalence of Cryptococcus neoformans var. neoformans (Serotype D) and Cryptococcus neoformans var. grubii (Serotype A) isolates in New York City.纽约市新型隐球菌新型变种（血清型D）和新型隐球菌格特变种（血清型A）分离株的流行情况。
J Clin Microbiol. 2000 May;38(5):1974-6. doi: 10.1128/JCM.38.5.1974-1976.2000.
2
Molecular epidemiology of Cryptococcus neoformans in Brazil and the United States: evidence for both local genetic differences and a global clonal population structure.巴西和美国新型隐球菌的分子流行病学：本地遗传差异和全球克隆种群结构的证据
J Clin Microbiol. 1997 Sep;35(9):2243-51. doi: 10.1128/jcm.35.9.2243-2251.1997.
3
In vitro susceptibilities of clinical and environmental isolates of Cryptococcus neoformans to five antifungal drugs.新型隐球菌临床分离株和环境分离株对五种抗真菌药物的体外敏感性
Antimicrob Agents Chemother. 1996 Mar;40(3):822-4. doi: 10.1128/AAC.40.3.822.
4
Electrophoretic karyotype and in vitro antifungal susceptibility of Cryptococcus neoformans isolates from AIDS patients.艾滋病患者新型隐球菌分离株的电泳核型及体外抗真菌药敏性
Diagn Microbiol Infect Dis. 1995 Nov;23(3):99-103. doi: 10.1016/0732-8893(95)00169-7.
5
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans.艾滋病时代的隐球菌病——新型隐球菌发现100年后
Clin Microbiol Rev. 1995 Oct;8(4):515-48. doi: 10.1128/CMR.8.4.515.
6
Clinical epidemiological study of 171 cases of cryptococcosis.171例隐球菌病的临床流行病学研究
Clin Infect Dis. 1994 Mar;18(3):369-80. doi: 10.1093/clinids/18.3.369.
7
Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C).用于分离新型隐球菌变种新型隐球菌（血清型A和D）和新型隐球菌变种格特隐球菌（血清型B和C）的改良诊断培养基。
J Clin Microbiol. 1982 Mar;15(3):535-7. doi: 10.1128/jcm.15.3.535-537.1982.
8
Separation of chromosomes of Cryptococcus neoformans by pulsed field gel electrophoresis.通过脉冲场凝胶电泳分离新型隐球菌的染色体
Infect Immun. 1989 Sep;57(9):2624-7. doi: 10.1128/iai.57.9.2624-2627.1989.
9
Cryptococcus neoformans varieties as agents of cryptococcosis in Brazil.巴西新型隐球菌变种作为隐球菌病的病原体
Mycopathologia. 1992 Sep;119(3):133-6. doi: 10.1007/BF00448809.

来自巴西、智利和委内瑞拉的新型隐球菌临床分离株的抗真菌药敏性、种类及电泳核型

Antifungal susceptibilities, varieties, and electrophoretic karyotypes of clinical isolates of Cryptococcus neoformans from Brazil, Chile, and Venezuela.

作者信息

Calvo B M, Colombo A L, Fischman O, Santiago A, Thompson L, Lazera M, Telles F, Fukushima K, Nishimura K, Tanaka R, Myiajy M, Moretti-Branchini M L

机构信息

Universidad del Zulia-Luz, Maracaibo, Venezuela.

出版信息

J Clin Microbiol. 2001 Jun;39(6):2348-50. doi: 10.1128/JCM.39.6.2348-2350.2001.

DOI:10.1128/JCM.39.6.2348-2350.2001
PMID:11376089
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC88143/
Abstract

One hundred clinical isolates of Cryptococcus neoformans from human immunodeficiency virus (HIV)-infected and non-HIV-infected patients from Brazil, Chile, and Venezuela were separated according to varieties and tested for antifungal susceptibility. A high susceptibility to antifungal agents was observed among all the isolates. The electrophoretic karyotyping of 51 strains revealed good discrimination among Cryptococcus neoformans var. neoformans strains.

摘要

从巴西、智利和委内瑞拉的人类免疫缺陷病毒（HIV）感染患者和非HIV感染患者中分离出100株新型隐球菌临床分离株，根据变种进行分类，并检测其抗真菌药敏性。所有分离株对抗真菌药物均表现出高度敏感性。对51株菌株进行的电泳核型分析显示，新型隐球菌变种新型隐球菌菌株之间有良好的区分度。